4-Methyl-2,5-methoxyphenylcyclopropylamine

2,5-Dimethoxy-4-methylphenylcyclopropylamine

2,5-Dimethoxy-4-methylphenylcyclopropylamine

Chemical compound

2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–20 mg and the duration is listed as 4–8 hours.[1] DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.

Quick Facts Names, Identifiers ...

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

Pharmacology

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.

See also

References

  1. [1]
    DMCPA Entry in PiHKAL
  2. [2]
    "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
Share this article:

This article uses material from the Wikipedia article 4-Methyl-2,5-methoxyphenylcyclopropylamine, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.